Skip to main content

Arsenal batch 11

Colorectal cancer screening: tests, ages and intervals

Colorectal screening can prevent cancer by finding precancerous lesions and can detect cancer earlier. For average-risk adults, major guidelines generally recommend starting at age 45. The best test is a validated option you will complete on schedule—with colonoscopy after every abnormal non-colonoscopy result.

Published by LongevityMate Editorial Team · Updated 2026-08-21 · 15 minute read

One-minute decision guide

The simple evidence-based protocol

Average-risk adults should follow local screening guidance, commonly beginning at age 45 and continuing regularly through 75. Strong options include annual FIT, stool DNA-FIT every 1–3 years, CT colonography every 5 years or colonoscopy every 10 years, with exact programs varying by country. Any abnormal stool or imaging screen needs timely diagnostic colonoscopy. Symptoms, prior polyps, inflammatory bowel disease, strong family history or hereditary syndromes require a different, often earlier pathway.See reference 1,See reference 2,See reference 3

Clinician comparing colorectal screening options with a patient using a simple colon diagram
On this page

One-minute decision guide

The simple evidence-based protocol

Average-risk adults should follow local screening guidance, commonly beginning at age 45 and continuing regularly through 75. Strong options include annual FIT, stool DNA-FIT every 1–3 years, CT colonography every 5 years or colonoscopy every 10 years, with exact programs varying by country. Any abnormal stool or imaging screen needs timely diagnostic colonoscopy. Symptoms, prior polyps, inflammatory bowel disease, strong family history or hereditary syndromes require a different, often earlier pathway.See reference 1,See reference 2,See reference 3

The 10 rules to remember

First principles: what this can actually change

Most colorectal cancers develop over years through identifiable precursor lesions, creating an opportunity to prevent disease by removal.See reference 1,See reference 2

Stool tests look for blood or altered DNA and must be repeated often; structural tests visualize the bowel and use longer intervals but involve preparation and procedural burdens.See reference 3,See reference 4

A screening program is a chain: invitation, completed test, follow-up of abnormal results, treatment and future surveillance. Benefit is lost when the chain breaks.See reference 5,See reference 6

A practical decision protocol

Stage
1. Risk group
What to do
Review age, symptoms, family history, prior polyps and bowel disease
Why it matters
Determines screening versus diagnostic or high-risk careSee reference 1,See reference 2
Stage
2. Choose test
What to do
Compare home stool testing, colonoscopy and imaging
Why it matters
Preferences influence completionSee reference 2,See reference 3
Stage
3. Complete correctly
What to do
Follow collection or bowel-preparation instructions
Why it matters
Poor preparation reduces accuracySee reference 3,See reference 4
Stage
4. Close the loop
What to do
Document the result, next due date and colonoscopy after abnormal tests
Why it matters
Follow-up creates the benefitSee reference 4,See reference 5

Timing and frequency

Decision
FIT
Practical answer
Usually every year in USPSTF options; follow the local program interval.See reference 3,See reference 4
Decision
Stool DNA-FIT
Practical answer
Every 1–3 years depending on the approved test and guideline.See reference 4,See reference 5
Decision
CT colonography
Practical answer
Every 5 years when used as a screening strategy, with colonoscopy after an abnormal result.See reference 5,See reference 6
Decision
Colonoscopy
Practical answer
Often every 10 years after a normal high-quality exam in average-risk adults; surveillance intervals differ.See reference 6,See reference 7

What to measure

Signal
Risk category
How
Record family history, genetics, polyps and bowel disease
Interpretation
High-risk people need tailored timingSee reference 4,See reference 5
Signal
Test quality
How
Check sample validity or bowel-preparation quality
Interpretation
An incomplete test may need repetitionSee reference 5,See reference 6
Signal
Result and follow-up
How
Record positive/negative and diagnostic completion
Interpretation
A positive stool test is not a cancer diagnosisSee reference 6,See reference 7
Signal
Next due date
How
Use the program or endoscopist recommendation
Interpretation
Prevents silent gaps in screeningSee reference 7,See reference 8

What the evidence actually shows

USPSTF modeling and evidence show that multiple stool-based and direct-visualization strategies reduce colorectal cancer mortality and gain life-years when completed with follow-up.See reference 1,See reference 3

Colonoscopy can find and remove precancerous lesions in one procedure, while FIT offers a low-burden home option that works only with regular repetition.See reference 4,See reference 6

No single option is best for everyone. Adherence and access can matter more than theoretical differences between recommended tests.See reference 7,See reference 8

Evidence strength by claim

Claim
Screening ages 45–75 reduces colorectal cancer burden
Confidence
High
Important boundary
Applies to average-risk asymptomatic adultsSee reference 1,See reference 2
Claim
Annual FIT is an effective strategy
Confidence
High
Important boundary
Every positive test requires colonoscopySee reference 3,See reference 4
Claim
Colonoscopy every 10 years is effective
Confidence
High
Important boundary
Quality, preparation and procedural risk matterSee reference 5,See reference 6
Claim
A negative test rules out future cancer
Confidence
Low
Important boundary
Screening must continue at the recommended intervalSee reference 7,See reference 8,See reference 9

Limits and common overclaims

Stool tests can miss lesions and can be positive for reasons other than cancer.See reference 3,See reference 7

Colonoscopy can miss lesions and carries small risks of bleeding, perforation and sedation complications.See reference 5,See reference 8

USPSTF age and interval examples are U.S.-based; national programs differ, and individual history overrides average-risk schedules.See reference 9,See reference 10

A four-step implementation plan

  • 1. Review age, symptoms, family history, prior polyps and bowel diseaseSee reference 1
  • 2. Compare home stool testing, colonoscopy and imagingSee reference 2
  • 3. Follow collection or bowel-preparation instructionsSee reference 3
  • 4. Document the result, next due date and colonoscopy after abnormal testsSee reference 4

Troubleshooting

Problem
Positive FIT
Likely issue
Blood was detected but the cause is unknown
Better next step
Arrange diagnostic colonoscopy; do not repeat FIT to cancel itSee reference 2,See reference 3
Problem
Poor bowel preparation
Likely issue
The lining was not fully visible
Better next step
Follow the endoscopist's repeat recommendationSee reference 4,See reference 5
Problem
Family member had early cancer
Likely issue
Average-risk timing may be inappropriate
Better next step
Get individualized risk assessment and earlier testing if indicatedSee reference 6,See reference 7
Problem
Overdue but worried about colonoscopy
Likely issue
Procedural burden is blocking all screening
Better next step
Discuss a validated stool option while preserving follow-up commitmentSee reference 8,See reference 9

Safety and when to get medical help

Rectal bleeding, black stool, unexplained iron-deficiency anemia, persistent change in bowel habits, abdominal mass, severe pain or unintended weight loss needs medical evaluation, not routine screening. After colonoscopy, severe or worsening abdominal pain, fever, heavy bleeding, dizziness or fainting requires urgent care.See reference 1,See reference 5,See reference 9

Who is most likely to benefit

Average-risk adults in the guideline-recommended age range who are due for screening.See reference 2,See reference 4

People who choose a lower-burden home test and can reliably repeat it and complete colonoscopy if positive.See reference 5,See reference 7

Higher-risk people who enter an individualized surveillance program based on family history, genetics, bowel disease or prior polyps.See reference 8,See reference 10

Track five things

Frequently asked questions

At what age should screening start?

Many current guidelines start average-risk screening at 45; follow your country's program and individual risk.See reference 1

Is FIT as good as colonoscopy?

Both are recommended strategies with different tradeoffs. FIT must be repeated regularly and every positive result needs colonoscopy.See reference 2

Can I repeat FIT after a positive result?

No. A second negative test does not cancel the need for diagnostic colonoscopy.See reference 3

Does a positive stool test mean cancer?

No. It means further evaluation is required.See reference 4

How often is colonoscopy needed?

Often every 10 years after a normal high-quality average-risk exam, but findings and risk can shorten the interval.See reference 5

What if I have symptoms?

Symptoms require diagnostic evaluation regardless of age or prior screening.See reference 6

When can screening stop?

USPSTF recommends individualized decisions from 76–85 and stopping after 85; other countries may differ.See reference 7

Can diet replace screening?

No. Healthy habits may reduce risk but do not replace recommended testing.See reference 8

Connect this decision to your wider health picture

LongevityMate helps organize measurements, symptoms, habits and trends so a test or treatment stays in context instead of becoming the whole plan.

See how LongevityMate works

References

  1. 1. Colorectal Cancer: Screening

    U.S. Preventive Services Task ForceGuideline

  2. 2. Colorectal Cancer Screening Guideline

    American College of GastroenterologyGuideline

  3. 3. Colorectal Cancer Screening Guideline

    American Cancer SocietyGuideline

  4. 4. Colorectal Cancer Screening Tests

    National Cancer InstituteOfficial guidance

  5. 5. FIT Screening and Colorectal Cancer Mortality

    Annals of Internal MedicineObservational study

  6. 6. Flexible Sigmoidoscopy Screening Trial

    New England Journal of MedicineRandomized trial

  7. 7. Colonoscopy Screening Trial

    New England Journal of MedicineRandomized trial

  8. 8. Stool DNA Testing for Colorectal Cancer

    New England Journal of MedicineObservational study

  9. 9. Harms of Colorectal Cancer Screening

    USPSTF Evidence ReviewSystematic review

  10. 10. Follow-up After Positive FIT

    GastroenterologyObservational study

Editorial transparency

Published by
LongevityMate Editorial Team
Published
Updated

Medical disclaimer

This guide provides general health education. It does not diagnose a condition, prescribe treatment, replace individualized medical care, or guarantee a health or longevity outcome.